Screener
AptarGroup ATR Pharma — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AptarGroup in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: AptarGroup’s 10-K, filed February 6, 2026.
- Filed
- Feb 6, 2026, 11:57 AM EST
- Fiscal year
- FY2025
- Accession
- 0000896622-26-000007
| In thousands / Year Ended December 31, | 2025 | 2024 | 2023 |
|---|---|---|---|
| Transfer of Corporate Expenditures (8) | (3,699) | (5,747) | (34,502) |
| Capital Expenditures | $270,419 | $276,481 | $312,342 |
| Total Assets: | |||
| Pharma | $2,283,609 | $2,057,586 | $2,111,779 |
| Beauty | 1,691,850 | 1,392,491 | 1,412,203 |
| Closures | 799,403 | 746,127 | 765,930 |
| Total Assets for Reportable Segments | 4,774,862 | 4,196,204 | 4,289,912 |
| Corporate & Other | 477,857 | 236,074 | 161,978 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is AptarGroup's pharma — total assets?
- AptarGroup (ATR) reported pharma — total assets of $2.28B in Q4 2025.
- What does pharma — total assets mean?
- The aggregate value of all resources, including property, plant, equipment, inventory, and intangible assets, controlled by the Pharma segment. This metric represents the capital base utilized to generate revenue within the pharmaceutical dispensing market.
Ask your AI about AptarGroup's pharma — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude